Guardian Pharmacy Services Inc. (GRDN)
NYSE NYSE Primary 
Guardian Pharmacy Services Q2 Earnings Call Highlights
Guardian Pharmacy Services NYSE: GRDN reported second-quarter revenue growth of 2% year over year to $351.2 million, while adjusted EBITDA increased 19% to $29.7 million, as the company said it continued to offset profitability pressure from Inflation Reduction Act-related drug pricing reductions.
Guardian Pharmacy Services, Inc. (GRDN) Q2 2026 Earnings Call Transcript
Guardian Pharmacy Services, Inc. (GRDN) Q2 2026 Earnings Call Transcript
Guardian Pharmacy (GRDN) Surges 8.8%: Is This an Indication of Further Gains?
Guardian Pharmacy (GRDN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Guardian Pharmacy Services, Inc. (GRDN) Hit a 52 Week High, Can the Run Continue?
Guardian Pharmacy (GRDN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Guardian Pharmacy Services, Inc. (GRDN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Guardian Pharmacy Services, Inc. (GRDN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Guardian Pharmacy Services Q1 Earnings Call Highlights
Guardian Pharmacy Services NYSE: GRDN reported what executives described as a solid first quarter of 2026, with management saying the company successfully navigated the initial implementation of the Inflation Reduction Act's new framework while maintaining its full-year revenue outlook and raising adjusted EBITDA guidance.
Guardian Pharmacy Services (GRDN) Q1 Earnings and Revenues Surpass Estimates
Guardian Pharmacy Services (GRDN) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.21 per share a year ago.
Guardian Pharmacy Services, Inc. (GRDN) Q1 2026 Earnings Call Transcript
Guardian Pharmacy Services, Inc. (GRDN) Q1 2026 Earnings Call Transcript
Earnings Estimates Moving Higher for Guardian Pharmacy (GRDN): Time to Buy?
Guardian Pharmacy Services (GRDN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Guardian Pharmacy (GRDN) Soars 9.1%: Is Further Upside Left in the Stock?
Guardian Pharmacy (GRDN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Guardian Pharmacy Services (GRDN) Surpasses Q4 Earnings and Revenue Estimates
Guardian Pharmacy Services (GRDN) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.24 per share a year ago.
All You Need to Know About Guardian Pharmacy (GRDN) Rating Upgrade to Buy
Guardian Pharmacy (GRDN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
